生物防御市场：按产品（炭疽菌、肉毒桿菌、辐射），按最终用户（门诊医疗中心、医院、军队）-2023-2030 年全球预测

全球生物防御市场预计到2023年将大幅增长183.6亿美元，年复合成长率为11.18%，预计到2030年将达到惊人的387.3亿美元。

FPNV定位矩阵

FPNV定位矩阵对于评估全球生物防御市场至关重要。通过检查业务战略和产品满意度的关键指标，我们对供应商进行全面评估，使您能够根据您的具体需求做出明智的资讯。这种高级分析将供应商分为四个像限，并取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市场份额分析

市场份额分析可以深入了解供应商在特定市场领域的当前地位。比较供应商对整体收入、客户群和其他关键指标的贡献，可以帮助公司更好地了解他们在争夺市场份额时的表现以及面临的情况。该分析还揭示了特定行业的竞争程度、积累和合併的优势以及研究基准年的合併特征。

本报告提供了以下几点见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开发：提供有关利润丰厚的新兴市场的详细资讯，并分析其在成熟市场的渗透率。

3. 市场多元化：提供有关新产品发布、未开发地区、最新发展和投资的详细资讯。

4.市场趋势：全面了解COVID-19、俄罗斯-乌克兰衝突和高通胀的累积影响。

5、竞争评估与资讯：对主要企业的市场份额、战略、产品、认证、法规状况、专利状况、製造能力等进行综合评价。

6. 产品开发和创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告回答了以下问题：

1.全球生物防御市场规模和预测是多少？

2.在预测期内，COVID-19 对全球生物防御市场的抑制要素和影响是什么？

3. 在预测期内，全球生物防御市场需要投资哪些产品/细分市场/应用/领域？

4.你们在全球生物防御市场的竞争策略是什么？

5. 全球生物防御市场的技术趋势和法律规范是什么？

6.全球生物防御市场主要厂商的市场份额是多少？

7. 哪些型态和战略倡议被认为适合进入全球生物防御市场？

目录

第1章前言

第2章调查方法

第3章执行摘要

第4章市场概况

第5章市场洞察

• 市场动态
  • 促进因素
    • 政府采取的有利倡议
    • 埃博拉病毒、齐瓦病毒等各种病原体的流行率增加
    • 疾病监测的重要性日益增加
  • 抑制因素
    • 开发中国家的市场渗透率低
  • 机会
    • 发达国家加大研发力度
    • 生物技术的技术进步
  • 课题
    • 更大的投资和更长的临床程序
• 市场趋势
• COVID-19 的累积影响
• 俄罗斯-乌克兰衝突的累积影响
• 高通胀的累积效应
• 波特五力分析
• 价值炼和关键路径分析
• 法律规范
• 客户定制

第6章生物防御市场：副产品

• 炭疽菌
• 肉毒中毒
• 辐射
• 天花

第7章生物防御市场：按最终用户分类

• 门诊治疗中心
• 医院
• 军队
• 调查机构

第8章美洲生物防御市场

• 阿根廷
• 巴西
• 加拿大
• 墨西哥
• 美国

第9章亚太生物防御市场

• 澳大利亚
• 中国
• 印度
• 印尼
• 日本
• 马来西亚
• 菲律宾
• 新加坡
• 韩国
• 台湾
• 泰国
• 越南

第10章欧洲、中东和非洲生物防御市场

• 丹麦
• 埃及
• 芬兰
• 法国
• 德国
• 以色列
• 意大利
• 荷兰
• 尼日利亚
• 挪威
• 波兰
• 卡塔尔
• 俄罗斯
• 沙特阿拉伯
• 南非
• 西班牙
• 瑞典
• 瑞士
• 土耳其
• 阿拉伯联合酋长国
• 英国

第11章竞争形势

• FPNV定位矩阵
• 市场份额分析：主要企业
• 竞争情景分析：主要企业

第12章上市公司名单

第13章附录

• 讨论指南
• 关于许可和定价

The Global Biodefense Market is forecasted to grow significantly, with a projected USD 18.36 billion in 2023 at a CAGR of 11.18% and expected to reach a staggering USD 38.73 billion by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Biodefense Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Biodefense Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product, market is studied across Anthrax, Botulism, Radiation, and Small Pox. The Botulism is projected to witness significant market share during forecast period.

Based on End-User, market is studied across Ambulatory Care Centers, Hospitals, Military, and Research Organizations. The Research Organizations is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Biodefense Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Biodefense Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Biodefense Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Biodefense Market?

4. What is the competitive strategic window for opportunities in the Global Biodefense Market?

5. What are the technology trends and regulatory frameworks in the Global Biodefense Market?

6. What is the market share of the leading vendors in the Global Biodefense Market?

7. What modes and strategic moves are considered suitable for entering the Global Biodefense Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Biodefense Market, by Product, 2022 vs 2030
• 4.3. Biodefense Market, by End-User, 2022 vs 2030
• 4.4. Biodefense Market, by Region, 2022 vs 2030

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Presence of favorable government initiatives
    • 5.1.1.2. Growing prevalence of various agents such as Ebola virus, Ziva virus, and others
    • 5.1.1.3. Increasing importance of disease surveillance
  • 5.1.2. Restraints
    • 5.1.2.1. Low market penetration in developing and underdeveloped countries
  • 5.1.3. Opportunities
    • 5.1.3.1. Rising initiatives for research & developments in developed countries
    • 5.1.3.2. Technological advancement in biotechnology
  • 5.1.4. Challenges
    • 5.1.4.1. High time investment and longer clinical procedures
• 5.2. Market Trends
• 5.3. Cumulative Impact of COVID-19
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework
• 5.9. Client Customization

6. Biodefense Market, by Product

• 6.1. Introduction
• 6.2. Anthrax
• 6.3. Botulism
• 6.4. Radiation
• 6.5. Small Pox

7. Biodefense Market, by End-User

• 7.1. Introduction
• 7.2. Ambulatory Care Centers
• 7.3. Hospitals
• 7.4. Military
• 7.5. Research Organizations

8. Americas Biodefense Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Biodefense Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Biodefense Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. FPNV Positioning Matrix
• 11.2. Market Share Analysis, By Key Player
• 11.3. Competitive Scenario Analysis, By Key Player

12. List of Company Mentioned

13. Appendix

• 13.1. Discussion Guide
• 13.2. License & Pricing

LIST OF FIGURES

• FIGURE 1. BIODEFENSE MARKET RESEARCH PROCESS
• FIGURE 2. BIODEFENSE MARKET SIZE, 2022 VS 2030
• FIGURE 3. BIODEFENSE MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. BIODEFENSE MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
• FIGURE 5. BIODEFENSE MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
• FIGURE 6. BIODEFENSE MARKET SIZE, BY REGION, 2022 VS 2030 (%)
• FIGURE 7. BIODEFENSE MARKET DYNAMICS
• FIGURE 8. BIODEFENSE MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 9. BIODEFENSE MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS BIODEFENSE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 11. UNITED STATES BIODEFENSE MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 12. ASIA-PACIFIC BIODEFENSE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 13. EUROPE, MIDDLE EAST & AFRICA BIODEFENSE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 14. BIODEFENSE MARKET, FPNV POSITIONING MATRIX, 2022
• FIGURE 15. BIODEFENSE MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

• TABLE 1. BIODEFENSE MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
• TABLE 3. BIODEFENSE MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 5. BIODEFENSE MARKET SIZE, BY ANTHRAX, BY REGION, 2018-2030 (USD MILLION)
• TABLE 6. BIODEFENSE MARKET SIZE, BY BOTULISM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. BIODEFENSE MARKET SIZE, BY RADIATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 8. BIODEFENSE MARKET SIZE, BY SMALL POX, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 10. BIODEFENSE MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. BIODEFENSE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. BIODEFENSE MARKET SIZE, BY MILITARY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. BIODEFENSE MARKET SIZE, BY RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. AMERICAS BIODEFENSE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 15. AMERICAS BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 16. AMERICAS BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 17. ARGENTINA BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 18. ARGENTINA BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 19. BRAZIL BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 20. BRAZIL BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 21. CANADA BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 22. CANADA BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 23. MEXICO BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 24. MEXICO BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 25. UNITED STATES BIODEFENSE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 26. UNITED STATES BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 27. UNITED STATES BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 28. ASIA-PACIFIC BIODEFENSE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 29. ASIA-PACIFIC BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 30. ASIA-PACIFIC BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 31. AUSTRALIA BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 32. AUSTRALIA BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 33. CHINA BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 34. CHINA BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 35. INDIA BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 36. INDIA BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 37. INDONESIA BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 38. INDONESIA BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 39. JAPAN BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 40. JAPAN BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 41. MALAYSIA BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 42. MALAYSIA BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 43. PHILIPPINES BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 44. PHILIPPINES BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 45. SINGAPORE BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 46. SINGAPORE BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 47. SOUTH KOREA BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 48. SOUTH KOREA BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 49. TAIWAN BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 50. TAIWAN BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 51. THAILAND BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 52. THAILAND BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 53. VIETNAM BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 54. VIETNAM BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 55. EUROPE, MIDDLE EAST & AFRICA BIODEFENSE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 56. EUROPE, MIDDLE EAST & AFRICA BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 57. EUROPE, MIDDLE EAST & AFRICA BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 58. DENMARK BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 59. DENMARK BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 60. EGYPT BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 61. EGYPT BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 62. FINLAND BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 63. FINLAND BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 64. FRANCE BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 65. FRANCE BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 66. GERMANY BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 67. GERMANY BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 68. ISRAEL BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 69. ISRAEL BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 70. ITALY BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 71. ITALY BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 72. NETHERLANDS BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 73. NETHERLANDS BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 74. NIGERIA BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 75. NIGERIA BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 76. NORWAY BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 77. NORWAY BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 78. POLAND BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 79. POLAND BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 80. QATAR BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 81. QATAR BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 82. RUSSIA BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 83. RUSSIA BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 84. SAUDI ARABIA BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 85. SAUDI ARABIA BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 86. SOUTH AFRICA BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 87. SOUTH AFRICA BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 88. SPAIN BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 89. SPAIN BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 90. SWEDEN BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 91. SWEDEN BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 92. SWITZERLAND BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 93. SWITZERLAND BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 94. TURKEY BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 95. TURKEY BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 96. UNITED ARAB EMIRATES BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 97. UNITED ARAB EMIRATES BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 98. UNITED KINGDOM BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 99. UNITED KINGDOM BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 100. BIODEFENSE MARKET, FPNV POSITIONING MATRIX, 2022
• TABLE 101. BIODEFENSE MARKET SHARE, BY KEY PLAYER, 2022
• TABLE 102. BIODEFENSE MARKET LICENSE & PRICING